Vimarsana
Biggest News Aggregation in the World

Page 2 - Peter Steiger News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Peter Steiger. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Peter Steiger Today - Breaking & Trending Today

Kapazitäten auf Intensivstationen - Politikerin fordert, dass ungeimpfte Corona-Patienten warten müssen - Vimarsana News

Kapazitäten auf Intensivstationen - Politikerin fordert, dass ungeimpfte Corona-Patienten warten müssen

Das Zürcher Unispital muss dringende OPs verschieben. Dringend zu Behandelnde sollten gegenüber ungeimpften Covid-19-Hospitalisierten Vorrang haben, so Politikerin Verena Herzog.

Source: 20min.ch
Ungeimpfte Patienten sollen im Spital auf Warteliste - Vimarsana News

Ungeimpfte Patienten sollen im Spital auf Warteliste

Zürcher Kliniken müssen wegen Überlastung dringende OPs verschieben. Eine Schweizer Politikerin sorgt nun mit einer Forderung für Aufregung.

Source: heute.at
Swiss doctors limit use of remdesivir even as government in talks to procure more - Vimarsana News

Swiss doctors limit use of remdesivir even as government in talks to procure more

Swiss doctors limit remdesivir use as government looks to procure more US firm Gilead set the price for remdesivir at CHF380.50 per dose for developed countries. Multiple doses are a typical treatment course. Mtva - Media Service Support And Asset Management Fund Swiss doctors are taking a cautious approach to the use of remdesivir for treating Covid-19 in the midst of emerging evidence from the World Health Organisation on the drug's ineffectiveness. Yet, the Swiss authorities moved ahead with an authorisation of the treatment and are making efforts to procure more of it. This content was ...

Swiss doctors limit remdesivir as government looks to procure more - Vimarsana News

Swiss doctors limit remdesivir as government looks to procure more

Swiss doctors limit remdesivir use as government looks to procure more US firm Gilead set the price for remdesivir at CHF380.50 per dose for developed countries. Multiple doses are a typical treatment course. Mtva - Media Service Support And Asset Management Fund Swiss doctors are taking a cautious approach to the use of remdesivir for treating Covid-19 in the midst of emerging evidence from the World Health Organisation on the drug's ineffectiveness. Yet, the Swiss authorities moved ahead with an authorisation of the treatment and are making efforts to procure more of it. This content was ...